Efficacy of Xuebijing Injection for Acute Pancreatitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Efficacy of Xuebijing Injection for Acute Pancreatitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Background and Aim. Xuebijing injection is a traditional Chinese medicine compound for the improvement of systemic inflammation response. This meta-analysis of randomized controlled trials (RCTs) aimed to explore the clinical efficacy and safety of Xuebijing injection for the treatment of acute panc...

Full description

Bibliographic Details
Main Authors:	Hongxin Chen, Zhaohui Bai, Hongyu Li, Yanyan Wu, Haijuan Yao, Le Wang, Hanyang Lin, Zhenhua Tong, Rolf Teschke, Xingshun Qi
Format:	Article
Language:	English
Published:	Hindawi Limited 2021-01-01
Series:	Evidence-Based Complementary and Alternative Medicine
Online Access:	http://dx.doi.org/10.1155/2021/6621368

Similar Items

Xuebijing Injection Combined with Antibiotics for the Treatment of Spontaneous Bacterial Peritonitis in Liver Cirrhosis: A Meta-Analysis
by: Dan Han, et al.
Published: (2018-01-01)

Efficacy and Safety of Xuebijing Injection Combined With Ulinastatin as Adjunctive Therapy on Sepsis: A Systematic Review and Meta-Analysis
by: Guochao Chen, et al.
Published: (2018-07-01)

Analysis of the Efficacy and Mechanism of Action of Xuebijing Injection on ARDS Using Meta-Analysis and Network Pharmacology
by: Yun Zhang, et al.
Published: (2021-01-01)

Efficacy and safety of Xuebijing injection in the treatment of vascular endothelial injury in sepsis patients: A meta-analysis
by: Jia-Wen Zhang, et al.
Published: (2021-06-01)

Efficacy of Xuebijing Injection for Sepsis (EXIT-SEP): protocol for a randomised controlled trial
by: Junhua Zhang, et al.
Published: (2019-08-01)

Efficacy of Xuebijing injection for the treatment of coronavirus disease 2019 via network pharmacology
by: Yu-Liang Zhang, et al.
Published: (2020-06-01)

Effects of Xuebijing injection combined with ulinastatin on endotoxin and inflammatory factors in treatment of severe acute pancreatitis
by: Hua-Xin Xiao, et al.
Published: (2016-07-01)

Could Xuebijing Injection Reduce the Mortality of Severe Pneumonia Patients? A Systematic Review and Meta-Analysis
by: Juan Wang, et al.
Published: (2020-01-01)

Superior Stability of Hydroxysafflor Yellow A in Xuebijing Injection and the Associated Mechanism
by: Weiling Pu, et al.
Published: (2017-12-01)

Xuebijing Injection Promotes M2 Polarization of Macrophages and Improves Survival Rate in Septic Mice
by: Yan-Cun Liu, et al.
Published: (2015-01-01)

Examining the effector mechanisms of Xuebijing injection on COVID-19 based on network pharmacology
by: Wen-jiang Zheng, et al.
Published: (2020-10-01)

Metabolomic Insights Into the Synergistic Effect of Biapenem in Combination With Xuebijing Injection Against Sepsis
by: Li-Wei Liu, et al.
Published: (2020-04-01)

Treatment Effects of Xuebijing Injection in Severe Septic Patients with Disseminated Intravascular Coagulation
by: Qin Yin, et al.
Published: (2014-01-01)

Therapeutic Effect of Xuebijing, a Traditional Chinese Medicine Injection, on Rheumatoid Arthritis
by: Shutong Li, et al.
Published: (2020-01-01)

Mechanism of Xuebijing injection on hepatic ischemia-reperfusion injury based on network pharmacology
by: Yuan-Yuan Ding, et al.
Published: (2021-02-01)

Xuebijing Injection Maintains GRP78 Expression to Prevent Candida albicans–Induced Epithelial Death in the Kidney
by: Ting Shang, et al.
Published: (2020-01-01)

Reevaluation of the post-marketing safety of Xuebijing injection based on real-world and evidence-based evaluations
by: Can Wang, et al.
Published: (2019-01-01)

UHPLC-Q-TOF MS-Based Metabolic Analysis for the Therapeutic Efficacy of “Xuebijing Injection” against Sepsis-Induced Acute Lung Injury
by: Xuan Shi, et al.
Published: (2018-01-01)

Role of Terlipressin in Cirrhotic Patients with Ascites and without Hepatorenal Syndrome: A Systematic Review of Current Evidence
by: Zhaohui Bai, et al.
Published: (2020-01-01)

Efficacy and safety of Xuebijing injection and its influence on immunomodulation in acute exacerbations of chronic obstructive pulmonary disease: study protocol for a randomized controlled trial
by: Sheling Xie, et al.
Published: (2019-02-01)

The effect of Xuebijing on burn patients and its effect on pain and wound healing
by: Le Guan
Published: (2020-11-01)

Clinical effect of Xuebijing on oxidative stress, CRP, IL-6 and TNF-毩 in patients with acute pancreatitis
by: Yang Yu
Published: (2016-07-01)

GC/MS-based metabonomics approach reveals effects of Xuebijing injection in CLP induced septic rats
by: Yu Jiang, et al.
Published: (2019-09-01)

Paeoniflorin and Hydroxysafflor Yellow A in Xuebijing Injection Attenuate Sepsis-Induced Cardiac Dysfunction and Inhibit Proinflammatory Cytokine Production
by: Xin-Tong Wang, et al.
Published: (2021-04-01)

Effect of Xuebijing combined with ulinastatin on the homeostasis of sepsis patients
by: Wei Chen
Published: (2019-07-01)

Heat stress-induced disruption of endothelial barrier function is via PAR1 signaling and suppressed by Xuebijing injection.
by: Qiulin Xu, et al.
Published: (2015-01-01)

Identifying the molecular targets and mechanisms of xuebijing injection for the treatment of COVID-19 via network parmacology and molecular docking
by: Zhao Tianyu, et al.
Published: (2021-01-01)

Xuebijing Ameliorates Sepsis-Induced Lung Injury by Downregulating HMGB1 and RAGE Expressions in Mice
by: Qiao Wang, et al.
Published: (2015-01-01)

Mitigating the Effects of Xuebijing Injection on Hematopoietic Cell Injury Induced by Total Body Irradiation with γ rays by Decreasing Reactive Oxygen Species Levels
by: Deguan Li, et al.
Published: (2014-06-01)

Xuebijing Injection Alleviates Pam3CSK4-Induced Inflammatory Response and Protects Mice From Sepsis Caused by Methicillin-Resistant Staphylococcus aureus
by: Tiantian Li, et al.
Published: (2020-02-01)

Xuebijing Protects Against Septic Acute Liver Injury Based on Regulation of GSK-3β Pathway
by: Liping Cao, et al.
Published: (2021-04-01)

A Green Antioxidant Activity-Integrated Dual-Standard Method for Rapid Evaluation of the Quality of Traditional Chinese Medicine Xuebijing Injection by On-Line DPPH-CE-DAD
by: Jin Li, et al.
Published: (2016-01-01)

Effects of blood purification combined with Xuebijing on coagulation, immunity, inflammation and vascular factors in sepsis patients
by: Guang-Ke Cao, et al.
Published: (2019-07-01)

Antiseptic Activity of Ethnomedicinal Xuebijing Revealed by the Metabolomics Analysis Using UHPLC-Q-Orbitrap HRMS
by: Lihua Zuo, et al.
Published: (2018-03-01)

Prevalence of Splanchnic Vein Thrombosis in Pancreatitis: A Systematic Review and Meta-Analysis of Observational Studies
by: Wenda Xu, et al.
Published: (2015-01-01)

Effect of Xuebijing, thymopentin combined with symptomatic treatment on inflammatory response process in elderly patients with severe pneumonia
by: Yan-Gang Zhu, et al.
Published: (2017-09-01)

Traditional chinese medicine Xuebijing treatment is associated with decreased mortality risk of patients with moderate paraquat poisoning.
by: Ping Gong, et al.
Published: (2015-01-01)

Role of D-dimer in the Development of Portal Vein Thrombosis in Liver Cirrhosis: A Meta-analysis
by: Junna Dai, et al.
Published: (2015-01-01)

Association between pancreatitis and fatty liver disease
by: GAO Fan, et al.
Published: (2017-01-01)

Correction: Traditional Chinese medicine Xuebijing treatment is associated with decreased mortality risk of patients with moderate paraquat poisoning.
by: Ping Gong, et al.
Published: (2015-01-01)